English
简体中文
Total: £ 56.28
Published Date: 2026-03-17 | Pages: 121 | Tables: 138 | Service & Software
The global Peptide Synthesis CDMO Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Peptide Synthesis CDMO (Contract Development and Manufacturing Organization) services refer to specialized services provided by companies that assist in the development and manufacturing of peptides for pharmaceutical, biotech, and research purposes. These services encompass a range of activities, from the initial design and synthesis of peptides to their large-scale production and regulatory compliance.
The North American market for Peptide Synthesis CDMO Services is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Peptide Synthesis CDMO Services is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Peptide Synthesis CDMO Services in Commercial is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Peptide Synthesis CDMO Services include Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic, ScinoPharm, JPT, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Peptide Synthesis CDMO Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Peptide Synthesis CDMO Services. The Peptide Synthesis CDMO Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Peptide Synthesis CDMO Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Peptide Synthesis CDMO Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bachem
CordenPharma
PolyPeptide
AmbioPharm
Genscript
Thermo Fisher
USV Peptides
Bio Basic
ScinoPharm
JPT
CBL
Piramal Pharma
CPC Scientific
Creative Peptides
Chinese Peptide Company
ChengDu ShengNuo Biotec
AppTec Co., Ltd.
GL Biochem
Segment by Type
GMP Services
Non-GMP Services
Segment by Application
Commercial
Scientific Research
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Peptide Synthesis CDMO Services companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Synthesis CDMO Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 GMP Services
1.2.3 Non-GMP Services
1.3 Market by Application
1.3.1 Global Peptide Synthesis CDMO Services Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Commercial
1.3.3 Scientific Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Synthesis CDMO Services Market Perspective (2021–2032)
2.2 Global Peptide Synthesis CDMO Services Growth Trends by Region
2.2.1 Global Peptide Synthesis CDMO Services Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Peptide Synthesis CDMO Services Historic Market Size by Region (2021–2026)
2.2.3 Peptide Synthesis CDMO Services Forecasted Market Size by Region (2027–2032)
2.3 Peptide Synthesis CDMO Services Market Dynamics
2.3.1 Peptide Synthesis CDMO Services Industry Trends
2.3.2 Peptide Synthesis CDMO Services Market Drivers
2.3.3 Peptide Synthesis CDMO Services Market Challenges
2.3.4 Peptide Synthesis CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Synthesis CDMO Services Players by Revenue
3.1.1 Global Top Peptide Synthesis CDMO Services Players by Revenue (2021–2026)
3.1.2 Global Peptide Synthesis CDMO Services Revenue Market Share by Players (2021–2026)
3.2 Global Top Peptide Synthesis CDMO Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Peptide Synthesis CDMO Services Revenue
3.4 Global Peptide Synthesis CDMO Services Market Concentration Ratio
3.4.1 Global Peptide Synthesis CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Synthesis CDMO Services Revenue in 2025
3.5 Global Key Players of Peptide Synthesis CDMO Services Head Offices and Areas Served
3.6 Global Key Players of Peptide Synthesis CDMO Services, Products and Applications
3.7 Global Key Players of Peptide Synthesis CDMO Services, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Peptide Synthesis CDMO Services Breakdown Data by Type
4.1 Global Peptide Synthesis CDMO Services Historic Market Size by Type (2021–2026)
4.2 Global Peptide Synthesis CDMO Services Forecasted Market Size by Type (2027–2032)
5 Peptide Synthesis CDMO Services Breakdown Data by Application
5.1 Global Peptide Synthesis CDMO Services Historic Market Size by Application (2021–2026)
5.2 Global Peptide Synthesis CDMO Services Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Peptide Synthesis CDMO Services Market Size (2021–2032)
6.2 North America Peptide Synthesis CDMO Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Peptide Synthesis CDMO Services Market Size by Country (2021–2026)
6.4 North America Peptide Synthesis CDMO Services Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Synthesis CDMO Services Market Size (2021–2032)
7.2 Europe Peptide Synthesis CDMO Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Peptide Synthesis CDMO Services Market Size by Country (2021–2026)
7.4 Europe Peptide Synthesis CDMO Services Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Peptide Synthesis CDMO Services Market Size (2021–2032)
8.2 Asia-Pacific Peptide Synthesis CDMO Services Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Peptide Synthesis CDMO Services Market Size by Region (2021–2026)
8.4 Asia-Pacific Peptide Synthesis CDMO Services Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Peptide Synthesis CDMO Services Market Size (2021–2032)
9.2 Latin America Peptide Synthesis CDMO Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Peptide Synthesis CDMO Services Market Size by Country (2021–2026)
9.4 Latin America Peptide Synthesis CDMO Services Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Synthesis CDMO Services Market Size (2021–2032)
10.2 Middle East & Africa Peptide Synthesis CDMO Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2021–2026)
10.4 Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Details
11.1.2 Bachem Business Overview
11.1.3 Bachem Peptide Synthesis CDMO Services Introduction
11.1.4 Bachem Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.1.5 Bachem Recent Development
11.2 CordenPharma
11.2.1 CordenPharma Company Details
11.2.2 CordenPharma Business Overview
11.2.3 CordenPharma Peptide Synthesis CDMO Services Introduction
11.2.4 CordenPharma Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.2.5 CordenPharma Recent Development
11.3 PolyPeptide
11.3.1 PolyPeptide Company Details
11.3.2 PolyPeptide Business Overview
11.3.3 PolyPeptide Peptide Synthesis CDMO Services Introduction
11.3.4 PolyPeptide Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.3.5 PolyPeptide Recent Development
11.4 AmbioPharm
11.4.1 AmbioPharm Company Details
11.4.2 AmbioPharm Business Overview
11.4.3 AmbioPharm Peptide Synthesis CDMO Services Introduction
11.4.4 AmbioPharm Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.4.5 AmbioPharm Recent Development
11.5 Genscript
11.5.1 Genscript Company Details
11.5.2 Genscript Business Overview
11.5.3 Genscript Peptide Synthesis CDMO Services Introduction
11.5.4 Genscript Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.5.5 Genscript Recent Development
11.6 Thermo Fisher
11.6.1 Thermo Fisher Company Details
11.6.2 Thermo Fisher Business Overview
11.6.3 Thermo Fisher Peptide Synthesis CDMO Services Introduction
11.6.4 Thermo Fisher Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.6.5 Thermo Fisher Recent Development
11.7 USV Peptides
11.7.1 USV Peptides Company Details
11.7.2 USV Peptides Business Overview
11.7.3 USV Peptides Peptide Synthesis CDMO Services Introduction
11.7.4 USV Peptides Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.7.5 USV Peptides Recent Development
11.8 Bio Basic
11.8.1 Bio Basic Company Details
11.8.2 Bio Basic Business Overview
11.8.3 Bio Basic Peptide Synthesis CDMO Services Introduction
11.8.4 Bio Basic Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.8.5 Bio Basic Recent Development
11.9 ScinoPharm
11.9.1 ScinoPharm Company Details
11.9.2 ScinoPharm Business Overview
11.9.3 ScinoPharm Peptide Synthesis CDMO Services Introduction
11.9.4 ScinoPharm Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.9.5 ScinoPharm Recent Development
11.10 JPT
11.10.1 JPT Company Details
11.10.2 JPT Business Overview
11.10.3 JPT Peptide Synthesis CDMO Services Introduction
11.10.4 JPT Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.10.5 JPT Recent Development
11.11 CBL
11.11.1 CBL Company Details
11.11.2 CBL Business Overview
11.11.3 CBL Peptide Synthesis CDMO Services Introduction
11.11.4 CBL Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.11.5 CBL Recent Development
11.12 Piramal Pharma
11.12.1 Piramal Pharma Company Details
11.12.2 Piramal Pharma Business Overview
11.12.3 Piramal Pharma Peptide Synthesis CDMO Services Introduction
11.12.4 Piramal Pharma Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.12.5 Piramal Pharma Recent Development
11.13 CPC Scientific
11.13.1 CPC Scientific Company Details
11.13.2 CPC Scientific Business Overview
11.13.3 CPC Scientific Peptide Synthesis CDMO Services Introduction
11.13.4 CPC Scientific Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.13.5 CPC Scientific Recent Development
11.14 Creative Peptides
11.14.1 Creative Peptides Company Details
11.14.2 Creative Peptides Business Overview
11.14.3 Creative Peptides Peptide Synthesis CDMO Services Introduction
11.14.4 Creative Peptides Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.14.5 Creative Peptides Recent Development
11.15 Chinese Peptide Company
11.15.1 Chinese Peptide Company Company Details
11.15.2 Chinese Peptide Company Business Overview
11.15.3 Chinese Peptide Company Peptide Synthesis CDMO Services Introduction
11.15.4 Chinese Peptide Company Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.15.5 Chinese Peptide Company Recent Development
11.16 ChengDu ShengNuo Biotec
11.16.1 ChengDu ShengNuo Biotec Company Details
11.16.2 ChengDu ShengNuo Biotec Business Overview
11.16.3 ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Introduction
11.16.4 ChengDu ShengNuo Biotec Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.16.5 ChengDu ShengNuo Biotec Recent Development
11.17 AppTec Co., Ltd.
11.17.1 AppTec Co., Ltd. Company Details
11.17.2 AppTec Co., Ltd. Business Overview
11.17.3 AppTec Co., Ltd. Peptide Synthesis CDMO Services Introduction
11.17.4 AppTec Co., Ltd. Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.17.5 AppTec Co., Ltd. Recent Development
11.18 GL Biochem
11.18.1 GL Biochem Company Details
11.18.2 GL Biochem Business Overview
11.18.3 GL Biochem Peptide Synthesis CDMO Services Introduction
11.18.4 GL Biochem Revenue in Peptide Synthesis CDMO Services Business (2021–2026)
11.18.5 GL Biochem Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Peptide Synthesis CDMO Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of GMP Services
Table 3. Key Players of Non-GMP Services
Table 4. Global Peptide Synthesis CDMO Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Peptide Synthesis CDMO Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Peptide Synthesis CDMO Services Market Size by Region (US$ Million), 2021–2026
Table 7. Global Peptide Synthesis CDMO Services Market Share by Region (2021–2026)
Table 8. Global Peptide Synthesis CDMO Services Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Peptide Synthesis CDMO Services Market Share by Region (2027–2032)
Table 10. Peptide Synthesis CDMO Services Market Trends
Table 11. Peptide Synthesis CDMO Services Market Drivers
Table 12. Peptide Synthesis CDMO Services Market Challenges
Table 13. Peptide Synthesis CDMO Services Market Restraints
Table 14. Global Peptide Synthesis CDMO Services Revenue by Players (US$ Million), 2021–2026
Table 15. Global Peptide Synthesis CDMO Services Market Share by Players (2021–2026)
Table 16. Global Top Peptide Synthesis CDMO Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Peptide Synthesis CDMO Services Revenue, 2025
Table 17. Ranking of Global Top Peptide Synthesis CDMO Services Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Peptide Synthesis CDMO Services Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Peptide Synthesis CDMO Services, Headquarters and Area Served
Table 20. Global Key Players of Peptide Synthesis CDMO Services, Products and Applications
Table 21. Global Key Players of Peptide Synthesis CDMO Services, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Peptide Synthesis CDMO Services Market Size by Type (US$ Million), 2021–2026
Table 24. Global Peptide Synthesis CDMO Services Revenue Market Share by Type (2021–2026)
Table 25. Global Peptide Synthesis CDMO Services Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Peptide Synthesis CDMO Services Revenue Market Share by Type (2027–2032)
Table 27. Global Peptide Synthesis CDMO Services Market Size by Application (US$ Million), 2021–2026
Table 28. Global Peptide Synthesis CDMO Services Revenue Market Share by Application (2021–2026)
Table 29. Global Peptide Synthesis CDMO Services Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Peptide Synthesis CDMO Services Revenue Market Share by Application (2027–2032)
Table 31. North America Peptide Synthesis CDMO Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Peptide Synthesis CDMO Services Market Size by Country (US$ Million), 2021–2026
Table 33. North America Peptide Synthesis CDMO Services Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Peptide Synthesis CDMO Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Peptide Synthesis CDMO Services Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Peptide Synthesis CDMO Services Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Peptide Synthesis CDMO Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Peptide Synthesis CDMO Services Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Peptide Synthesis CDMO Services Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Peptide Synthesis CDMO Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Peptide Synthesis CDMO Services Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Peptide Synthesis CDMO Services Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Peptide Synthesis CDMO Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (US$ Million), 2027–2032
Table 46. Bachem Company Details
Table 47. Bachem Business Overview
Table 48. Bachem Peptide Synthesis CDMO Services Product
Table 49. Bachem Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 50. Bachem Recent Development
Table 51. CordenPharma Company Details
Table 52. CordenPharma Business Overview
Table 53. CordenPharma Peptide Synthesis CDMO Services Product
Table 54. CordenPharma Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 55. CordenPharma Recent Development
Table 56. PolyPeptide Company Details
Table 57. PolyPeptide Business Overview
Table 58. PolyPeptide Peptide Synthesis CDMO Services Product
Table 59. PolyPeptide Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 60. PolyPeptide Recent Development
Table 61. AmbioPharm Company Details
Table 62. AmbioPharm Business Overview
Table 63. AmbioPharm Peptide Synthesis CDMO Services Product
Table 64. AmbioPharm Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 65. AmbioPharm Recent Development
Table 66. Genscript Company Details
Table 67. Genscript Business Overview
Table 68. Genscript Peptide Synthesis CDMO Services Product
Table 69. Genscript Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 70. Genscript Recent Development
Table 71. Thermo Fisher Company Details
Table 72. Thermo Fisher Business Overview
Table 73. Thermo Fisher Peptide Synthesis CDMO Services Product
Table 74. Thermo Fisher Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 75. Thermo Fisher Recent Development
Table 76. USV Peptides Company Details
Table 77. USV Peptides Business Overview
Table 78. USV Peptides Peptide Synthesis CDMO Services Product
Table 79. USV Peptides Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 80. USV Peptides Recent Development
Table 81. Bio Basic Company Details
Table 82. Bio Basic Business Overview
Table 83. Bio Basic Peptide Synthesis CDMO Services Product
Table 84. Bio Basic Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 85. Bio Basic Recent Development
Table 86. ScinoPharm Company Details
Table 87. ScinoPharm Business Overview
Table 88. ScinoPharm Peptide Synthesis CDMO Services Product
Table 89. ScinoPharm Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 90. ScinoPharm Recent Development
Table 91. JPT Company Details
Table 92. JPT Business Overview
Table 93. JPT Peptide Synthesis CDMO Services Product
Table 94. JPT Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 95. JPT Recent Development
Table 96. CBL Company Details
Table 97. CBL Business Overview
Table 98. CBL Peptide Synthesis CDMO Services Product
Table 99. CBL Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 100. CBL Recent Development
Table 101. Piramal Pharma Company Details
Table 102. Piramal Pharma Business Overview
Table 103. Piramal Pharma Peptide Synthesis CDMO Services Product
Table 104. Piramal Pharma Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 105. Piramal Pharma Recent Development
Table 106. CPC Scientific Company Details
Table 107. CPC Scientific Business Overview
Table 108. CPC Scientific Peptide Synthesis CDMO Services Product
Table 109. CPC Scientific Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 110. CPC Scientific Recent Development
Table 111. Creative Peptides Company Details
Table 112. Creative Peptides Business Overview
Table 113. Creative Peptides Peptide Synthesis CDMO Services Product
Table 114. Creative Peptides Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 115. Creative Peptides Recent Development
Table 116. Chinese Peptide Company Company Details
Table 117. Chinese Peptide Company Business Overview
Table 118. Chinese Peptide Company Peptide Synthesis CDMO Services Product
Table 119. Chinese Peptide Company Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 120. Chinese Peptide Company Recent Development
Table 121. ChengDu ShengNuo Biotec Company Details
Table 122. ChengDu ShengNuo Biotec Business Overview
Table 123. ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Product
Table 124. ChengDu ShengNuo Biotec Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 125. ChengDu ShengNuo Biotec Recent Development
Table 126. AppTec Co., Ltd. Company Details
Table 127. AppTec Co., Ltd. Business Overview
Table 128. AppTec Co., Ltd. Peptide Synthesis CDMO Services Product
Table 129. AppTec Co., Ltd. Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 130. AppTec Co., Ltd. Recent Development
Table 131. GL Biochem Company Details
Table 132. GL Biochem Business Overview
Table 133. GL Biochem Peptide Synthesis CDMO Services Product
Table 134. GL Biochem Revenue in Peptide Synthesis CDMO Services Business (US$ Million), 2021–2026
Table 135. GL Biochem Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Peptide Synthesis CDMO Services Picture
Figure 2. Global Peptide Synthesis CDMO Services Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Peptide Synthesis CDMO Services Market Share by Type: 2025 vs 2032
Figure 4. GMP Services Features
Figure 5. Non-GMP Services Features
Figure 6. Global Peptide Synthesis CDMO Services Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Peptide Synthesis CDMO Services Market Share by Application: 2025 vs 2032
Figure 8. Commercial Case Studies
Figure 9. Scientific Research Case Studies
Figure 10. Other Case Studies
Figure 11. Peptide Synthesis CDMO Services Report Years Considered
Figure 12. Global Peptide Synthesis CDMO Services Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Peptide Synthesis CDMO Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Peptide Synthesis CDMO Services Market Share by Region: 2025 vs 2032
Figure 15. Global Peptide Synthesis CDMO Services Market Share by Players in 2025
Figure 16. Global Peptide Synthesis CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Peptide Synthesis CDMO Services Revenue in 2025
Figure 18. North America Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Peptide Synthesis CDMO Services Market Share by Country (2021–2032)
Figure 20. United States Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Peptide Synthesis CDMO Services Market Share by Country (2021–2032)
Figure 24. Germany Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Peptide Synthesis CDMO Services Market Share by Region (2021–2032)
Figure 32. China Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Peptide Synthesis CDMO Services Market Share by Country (2021–2032)
Figure 40. Mexico Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Peptide Synthesis CDMO Services Market Share by Country (2021–2032)
Figure 44. Israel Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Peptide Synthesis CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Bachem Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 48. CordenPharma Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 49. PolyPeptide Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 50. AmbioPharm Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 51. Genscript Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 52. Thermo Fisher Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 53. USV Peptides Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 54. Bio Basic Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 55. ScinoPharm Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 56. JPT Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 57. CBL Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 58. Piramal Pharma Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 59. CPC Scientific Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 60. Creative Peptides Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 61. Chinese Peptide Company Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 62. ChengDu ShengNuo Biotec Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 63. AppTec Co., Ltd. Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 64. GL Biochem Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2021–2026)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
